Parkinson’s UK is joining forces with US Charity The Michael J. Fox Foundation and biopharma company Neurolixis to fund a £1.5 m clinical trial of an exciting new drug to combat Dyskinesia in people with Parkinson’s.
Featured image by Michael Longmire on Unsplash
Understanding Dementia Pre-diagnosis - Support Groups in Crawley. Waiting for a dementia diagnosis can be a difficult...
NHS Sussex: Let's Talk: Life After Stroke workshops NHS Sussex are holding a series of workshops to explore the...
The Disability Services Advocacy Team support with raising awareness of the different Disability Services benefits and...
0 Comments